Scientific Program (On-Demand Viewing)
| Plenary Session IV. | ||
| Channel 1, 2 | ||
|---|---|---|
| Chair: Myung Ju Ahn (Korea) | ||
| Time | Topic | Speaker |
| 08:50-09:30 | Present and Future Perspectives of First-Line Checkpoint Inhibitor for Stage IV Nonsmall Cell Lung Cancer | David Carbone (USA)VOD |
| Scientific Symposium II. Utilizing Machine Intelligence for Neoantigen Identification | |||
| Channel 1 | |||
|---|---|---|---|
| Chair: Dong Wan Kim (Korea) | |||
| Time | Topic | Speaker | |
| 09:40-10:05 | Utilizing Machine Intelligence for Neoantigen Identification | Jung Kyoon Choi (Korea)VOD | |
| 10:05-10:30 | Single cell analysis of the lung tumor microenvironment | Zemin Zhang (China)VOD | |
| 10:30-10:55 | Complex Genomic Alterations in Fusion-Positive Lung Adenocarcinoma | Young Seok Ju (Korea)VOD | |
| 10:55-11:20 | Genomic Heterogeneity of Advanced EGFR-Mutant Lung Cancer | Tae Min Kim (Korea)VOD | |
| Satellite Symposium IV. AstraZeneca | ||
| Channel 1, 2 | ||
|---|---|---|
| Chair: Kye Young Lee (Korea) | ||
| Time | Topic | Speaker |
| 11:30-12:20 | Is it time for a paradigm shift in first line treatment of advanced NSCLC? | Hye ryun Kim (Korea)VOD |
| Education Session VII. Management of Brain Metastases | ||
| Channel 1 | ||
|---|---|---|
| Chair: Si Yeol Song (Korea) | ||
| Time | Topic | Speaker |
| 12:40-13:05 | Hippocampal-Sparing WBRT | Vinai Gondi (USA)VOD |
| 13:05-13:30 | The Surgical Role for Brain Metastases | Se Hyuk Kim (Korea)VOD |
| 13:30-13:55 | New Medical Approaches for Brain Metastases | Sun Min Lim (Korea)VOD |
| 13:55-14:20 | Radiotherapeutic Approach for Patients with Multiple Brain Metastases from NSCLC | Hidefumi Aoyama (Japan)VOD |
| Oral Presentation III. | ||
| Channel 1 | ||
|---|---|---|
| Chair: Tae won Jang (Korea) | ||
| Time | Topic | Speaker |
| 14:30-14:40 | ANALYSIS OF DOSIMETRIC FACTORS ASSOCIATED WITH RADIATION PNEUMONITIS IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER TREATED WITH CONCURRENT CHEMORADIOTHERAPY FOLLOWED BY IMMUNOTHERAPY | Jeong Yun Jang (Korea)VOD |
| 14:40-14:50 | PROTON THERAPY REDUCED THE LIKELIHOOD OF SEVERE RADIATION-INDUCED LYMPHOPENIA IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER: COMPARATIVE STUDY OF PROTON VS PHOTON | Nalee Kim (Korea)VOD |
| 14:50-15:00 | RADIATION TO PRIMARY LESIONS IN PATIENTS WITH NON-OLIGOMETASTATIC NON-SMALL CELL LUNG CANCER WITH EGFR MUTATION WHO DO NOT PROGRESS AFTER TKI , RESULTS OF A PHASE II STUDY | Qifeng Wang (China)VOD |
| 15:00-15:10 | PREDICTION OF DELAYED LYMPHOPENIA AT THE TIME OF CONSOLIDATION IMMUNOTHERAPY AFTER CHEMORADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER | Byung-Hee Kang (Korea)VOD |
| 15:10-15:20 | INTRAOPERATIVE ELECTROMAGNETIC NAVIGATION WITH PERCUTANEOUS LOCALIZATION (EMPL) FOR PULMONARY NODULES | Stephanie Cerrone (USA)VOD |
| 15:20-15:30 | THE PATIENT-CLINICIAN DISCREPANCY OF PERCEPTION ON SYMPTOMS AFTER LUNG CANCER SURGERY FOR PATIENTS | Xing Wei (China)VOD |
| 15:30-15:40 | EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION STATUS AFFECTS THE DYNAMIC PATTERN OF SITE-SPECIFIC RECURRENCE IN CURATIVELY RESECTED LUNG ADENOCARCINOMA PATIENTS | Xianping Liu (China)VOD |
| 15:40-15:50 | NOVEL 3-DIMENSIONAL IMAGE SIMULATION FOR THORACOSCOPIC LUNG SEGMENTECTOMY IN PATIENTS WITH PULMONARY MALIGNANCY | Kenshiro Omura (Japan)VOD |
| 15:50-16:00 | COMPARING OF MICROCOIL LOCALIZATION AND HOOK WIRE LOCALIZATION FOR RESECTABLE PULMONARY SMALL NODULES: A PROSPECTIVE CONTROLLED STUDY | Xizhao Sui (China)VOD |
| 16:00-16:10 | TARGETED NGS APPLICATION TO EVALUATE RECURRENT IMPACT IN RESECTED EGFR-MUTATED LUNG ADENOCARCINOMA | In Ae Kim (Korea)VOD |
| Satellite Symposium V. Takeda Pharmaceuticals Korea CO., Ltd. | ||
| Channel 1 | ||
|---|---|---|
| Chair: Dae Ho Lee (korea) | ||
| Time | Topic | Speaker |
| 16:20-16:45 | A paradigm shift in ALK+NSCLC first-line treatment : Emerging role of Brigatinib | Hye Ryun Kim (Korea)VOD |
| Satellite Symposium VI. Roche Korea | ||
| Channel 1 | ||
|---|---|---|
| Chair: Byoung Chul Cho (korea) | ||
| Time | Topic | Speaker |
| 16:45-17:10 | Long term results of first line atezolizumab for patients with extensive stage small cell lung cancer | Hee Kyung Ahn (Korea)VOD |
| Plenary Session IV. | ||
| Channel 1, 2 | ||
|---|---|---|
| Chair: Myung Ju Ahn (Korea) | ||
| Time | Topic | Speaker |
| 08:50-09:30 | Present and Future Perspectives of First-Line Checkpoint Inhibitor for Stage IV Nonsmall Cell Lung Cancer | David Carbone (USA)VOD |
| Education Session VI. Lung Cancer Screening | ||
| Channel 2 | ||
|---|---|---|
| Chair: Jin Mo Goo (Korea) | ||
| Time | Topic | Speaker |
| 09:40-10:05 | Harms, benefits and cost effectiveness of lc screening | Harry J. de Koning (Netherlands)VOD |
| 10:05-10:30 | LDCT Screening in Non-Smokers in Taiwan | Pan Chyr Yang (Taiwan)VOD |
| 10:30-10:55 | Imaging Biomarkers in Lung Cancer Screening | Jin Mo Goo (Korea)VOD |
| 10:55-11:20 | Liquid Biomarkers in Lung Cancer Screening | Kye Young Lee (Korea)VOD |
| Satellite Symposium IV. AstraZeneca | ||
| Channel 1, 2 | ||
|---|---|---|
| Chair: Kye Young Lee (Korea) | ||
| Time | Topic | Speaker |
| 11:30-12:20 | Is it time for a paradigm shift in first line treatment of advanced NSCLC? | Hye ryun Kim (Korea)VOD |
| Education Session VIII. Immune Checkpoint Blockades in Lung Cancer | ||
| Channel 2 | ||
|---|---|---|
| Chair: Jae Cheol Lee (Korea) | ||
| Time | Topic | Speaker |
| 12:40-13:05 | Predictive Biomarkers for Efficacy of Immune Checkpoint Blockades in Lung Cancer | David Carbone (USA)VOD |
| 13:05-13:30 | Translation Research in Immunotherapy for Lung Cancer | Hidetoshi Hayashi (Japan)VOD |
| 13:30-13:55 | Is HyperProgression Real, or How Do We Prepare for It? | Jong Mu Sun (Korea)VOD |
| 13:55-14:20 | If Less is Good, More is Better, Combination of Immunotherapy | Dae Ho Lee (Korea)VOD |
| Education Session IX. Targeted Therapies for Lung Cancer | ||
| Channel 2 | ||
|---|---|---|
| Chair: Sang We Kim (Korea) | ||
| Time | Topic | Speaker |
| 14:30-14:55 | Evolution of Acquired Resistance to Targeted Therapies for Lung Cancer | Aaron Hata (USA)VOD |
| 14:55-15:20 | Treatment for Advanced ALK, ROS1-Rearranged Lung Cancer | Dong Wan Kim (Korea)VOD |
| 15:20-15:45 | Treatment for Advanced MET, RET-Altered Lung Cancer | Yasushi Goto (Japan)VOD |
| 15:45-16:10 | Treatment for Other Minor Mutations-Positive Advanced Lung Cancer | Eun Joo Kang (Korea)VOD |
| Policy Symposium. Tobacco Controls in US, Europe, and Asia | ||
| Channel 2 | ||
|---|---|---|
| Chair: Seung Hun Jang (Korea) | ||
| Time | Topic | Speaker |
| 16:20-16:45 | E-Cigarettes and Vaping-Related Lung Injury | Jay H. Ryu (USA)VOD |
| 16:45-17:10 | Current Status of Smoking Cessation with Heated Tobacco Products use in Japan | Takahiro Tabuchi (Japan)VOD |
| 17:10-17:35 | Current status of smoking cessation program in Korea and COVID-19 risk in smokers | Eun Mi Chun (Korea)VOD |
| 17:35-18:00 | Pharmacotherapy for Smoking Cessation and Nicotine Dependence | Hye Sook Choi (Korea)VOD |